ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

September 15, 1978

House, Senate Committee Increase FDA Funding, Drop User Fees

August 4, 1989

Letter to the Editors: Since 1992, Where Has All The OAM Grant Money Gone?

April 24, 1998

In Brief: Upton Not Planning To Leave NCI, As Hinted By Califano, Over New Ethics Regulations

March 30, 1979

Funding opportunities listed.

July 23, 2004

NCI Advisory Group, Other Cancer Meetings

July 29, 1983